A Real-World Study in Advanced Non–Small Cell Lung Cancer with KRAS Mutations

BACKGROUND: KRAS gene mutations are well known as a key driver of advanced non–small cell lung cancer (NSCLC). The impact of KRAS-mutant subtypes on the survival benefit from salvage chemotherapy is controversial. Here, we present a real-world study in patients across China with advanced NSCLC with...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Transl Oncol
Asıl Yazarlar: Lei, Lei, Wang, Wen-xian, Yu, Zong-yang, Liang, Xian-bin, Pan, Wei-wei, Chen, Hua-fei, Wang, Li-ping, Fang, Yong, Wang, Min, Xu, Chun-wei, Fang, Mei-yu
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Neoplasia Press 2019
Konular:
Original article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7031095/
https://ncbi.nlm.nih.gov/pubmed/31881505
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2019.12.004
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller